DINA Y. GEWAILY, M.D., M.S.
Dr. Gewaily is a native of Long Island, NY. She moved to Rhode Island upon enrolling in Brown University’s highly competitive 8 year combined medical program. While at Brown, she obtained Honors in every pre-clinical course along with three degrees: B.A., M.S., and an M.D.
Dr. Gewaily then moved to Pennsylvania where she completed her ophthalmology residency at the University of Pennsylvania’s prestigious Scheie Eye Institute. Subsequently, she was chosen as the first female surgical retina fellow in the history of the University of Pennsylvania’s Scheie Eye Institute. While at Brown and Penn, Dr. Gewaily participated in numerous research endeavors and her contributions have been presented on the regional, national, and international levels, resulting in over 15 peer reviewed journal publications to date. She has participated in several clinical research trials and will continue to serve as investigator of national retina trials. At Penn, she was a member of the surgical retina team that developed the first FDA-approved gene therapy in the United States for an inherited disease. Additionally, Dr. Gewaily has been invited as a peer reviewer for such journals as RETINA and the Cochrane Eye and Vision Group.
Dr. Gewaily is an experienced retinal surgeon who joins Lancaster Retina Specialists after several years in private practice in Philadelphia. She continues to serve on adjunct faculty at Penn’s Scheie Eye Institute as Assistant Professor of Ophthalmology, where she enjoys teaching Penn residents and fellows both medical and surgical retina. While Dr. Gewaily specializes in the broad medical and surgical management of diseases of the retina and vitreous, she has a particular interest in the treatment of macular degeneration, retinal vascular disease including advanced diabetic retinopathy, macular hole/pucker, and complex retinal detachments.